Xinqiao Hospital of Chongqing
Xinqiao Hospital of Chongqing
Explore linked clinical trials.32 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study | Insulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, metabolic disease, prediabetes syndrome | Not yet recruiting | Not stated | 2026-10-02 | NCT07854002 | |
| A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-25 | NCT07842185 | |
| Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-08-13 | NCT07763405 | |
| Tirofiban Combined With Aspirin in Moderate Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-08-12 | NCT07760922 | |
| Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS) | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-07-06 | NCT07682922 | |
| HBV Reactivation Prediction Model in Allo-HSCT | HBV Reactivation; HSCT | Not yet recruiting | Not stated | 2026-06-12 | NCT07644026 | |
| New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-03-19 | NCT05029141 | |
| Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation | Aneurysm, Brain Death, Coma, Consciousness Disorders, Death, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Unconsciousness, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, intracranial arterial disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 4 | 2026-03-03 | NCT06308952 | |
| 3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL) | aortic valve disorder, aortic valve insufficiency, cardiovascular disorder, heart disorder, heart valve disorder | Enrolling by invitation | Not applicable | 2026-02-10 | NCT07398911 | |
| Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases | autoimmune disease, immune system disorder | Not yet recruiting | Early phase 1 | 2026-01-23 | NCT07362758 | |
| Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies | B-cell Malignancies | Recruiting | Early phase 1 | 2026-01-20 | NCT07349849 | |
| Application of mRNA Immunotherapy Technology in EB Virus Related Diseases | EBV-associated Tumors | Not yet recruiting | Early phase 1 | 2026-01-20 | NCT07349836 | |
| Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-01-16 | NCT07347626 | |
| Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2025-12-31 | NCT06987305 | |
| A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT) | Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-12-26 | NCT05230914 | |
| Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms | Aneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Recruiting | Not stated | 2025-08-29 | NCT06943729 | |
| A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases | NSCLC Stage IV Without EGFR/ALK Mutation | Recruiting | Phase 2 | 2025-07-22 | NCT06947694 | |
| Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases | NSCLC Stage IV Without EGFR/ALK Mutation | Recruiting | Phase 2 | 2025-07-14 | NCT06953843 | |
| Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer | Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer | Recruiting | Phase 2 | 2025-07-14 | NCT06279351 | |
| Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer | non-small cell lung carcinoma | Not yet recruiting | Not stated | 2025-07-14 | NCT05909137 | |
| A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies | cancer, neoplasm | Recruiting | Not stated | 2025-07-14 | NCT05862259 | |
| Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2025-07-14 | NCT05754203 | |
| An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2025-07-14 | NCT05486650 | |
| Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis | Infections, Lung Injury, injury, interstitial lung disease, lung disorder, pneumonia, pneumonitis, radiation injury, radiation pneumonitis, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 1 / Phase 2 | 2025-07-14 | NCT05455034 | |
| Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-07-14 | NCT05147844 |